论文部分内容阅读
目的:观察痰热清注射液配合抗结核药治疗肺结核发热的临床疗效。方法:将186例肺结核发热患者随机分为2组。对照组7l例采用2SHRZ(E)/4HR方案治疗;治疗组115例在对照组治疗的基础上加痰热清注射液治疗,疗程均为10～14天。结果:有效率治疗组为59.13%,对照组为36.61%,2组比较,差异有非常显著性意义(P<0.01)。平均退热时间治疗组为(4.22±1.18)天,对照组为(6.14±1.86)天,2组比较,差异有非常显著性意义(P<0.01)。结论:痰热清注射液配合抗结核药治疗肺结核发热疗效优于单纯西药治疗。
Objective: To observe the Tanreqing injection with anti-tuberculosis drugs in the treatment of tuberculosis fever clinical efficacy. Methods: 186 cases of tuberculosis fever were randomly divided into two groups. Control group, 7l cases with 2SHRZ (E) / 4HR regimen; treatment group, 115 cases in the control group based on the treatment of Tanreqing injection, treatment were 10 to 14 days. Results: The effective treatment group was 59.13%, while the control group was 36.61%. There was significant difference between the two groups (P <0.01). The mean time of antipyretic treatment was (4.22 ± 1.18) days in the treatment group and (6.14 ± 1.86) days in the control group. There was significant difference between the two groups (P <0.01). Conclusion: Tanreqing injection with anti-tuberculosis drugs in the treatment of tuberculosis fever is superior to Western medicine alone.